Discovery of ximelagatran in an historical perspective

Semin Vasc Med. 2005 Aug;5(3):227-34. doi: 10.1055/s-2005-916161.

Abstract

The oral direct thrombin inhibitor ximelagatran is the first oral anticoagulant since the introduction of the vitamin K antagonists in the early 1940s. A comparison of the discovery and early clinical development of the two classes of oral anticoagulants reveals some similarities but also several differences that illustrate the change in drug discovery over the last half century.

Publication types

  • Historical Article
  • Review

MeSH terms

  • Animals
  • Anticoagulants / history*
  • Anticoagulants / pharmacology
  • Azetidines / history*
  • Azetidines / pharmacology
  • Benzylamines
  • Blood Coagulation / drug effects*
  • Cattle
  • Clinical Trials as Topic
  • Drug Design
  • Hemorrhage / chemically induced
  • History, 20th Century
  • Humans
  • Melilotus / adverse effects
  • Thrombin / antagonists & inhibitors
  • Vitamin K / antagonists & inhibitors
  • Warfarin / pharmacology

Substances

  • Anticoagulants
  • Azetidines
  • Benzylamines
  • Vitamin K
  • ximelagatran
  • Warfarin
  • Thrombin